Position in COLL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$13,212,963
+$789,689 QoQ
Shares Held
364,999
-2.8% QoQ
Ownership
1.12%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#25
of 277 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in COLL Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026LOOMIS SAYLES & CO L P holds $224,982,288 across 8 Drug Manufacturers - Specialty & Generic names. COLL ranks #6 (5.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALKS |
Alkermes plc.
|
1,585,518 | $83,081,142 | |
| 2 | SUPN |
Supernus Pharmaceuticals, Inc.
|
1,475,192 | $68,611,179 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
182,514 | $30,760,908 | |
| 4 | LNTH |
Lantheus Holdings, Inc.
|
141,424 | $15,689,578 | |
| 5 | ANIP |
Ani Pharmaceuticals Inc
|
162,792 | $13,475,921 | |
| 6 | COLL |
Collegium Pharmaceutical, Inc
This page
|
364,999 | $13,212,963 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
|
255 | $138,166 | |
| 8 | ZTS |
Zoetis Inc.
|
173 | $12,431 |
All Filings in COLL
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,212,963 | 364,999 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $12,423,274 | 375,666 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $15,397,944 | 332,569 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $11,122,620 | 317,880 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $9,969,140 | 337,137 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $5,593,024 | 187,371 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $3,122 | 109 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $737,058 | 19,075 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $6,482,149 | 201,309 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $10,557,176 | 271,952 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $8,499,250 | 276,129 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $6,115,585 | 273,628 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $4,431,000 | 206,189 | Shares | Defined | 2023-08-11 | |
| No filing history on record for this holder in this stock. | ||||||